Alanquihan, Eufracia L.

HRN: 21-33-80  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/28/2022
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
05/28/2022
06/03/2022
IVTT
4.5g
Q6
Sepsis
Waiting Final Action 

Indication:      Type of Infection:      Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: